Clinical Trials Logo

Clinical Trial Summary

A randomized controlled trial was conducted for testing the efficacy of a novel avatar-based intervention (IG), that was compared with a control group (CG) for women with female orgasmic disorder (FOD). Participants were 31 women who were randomly assigned to the intervention or the control conditions. Intervention was based on the cognitive behavioral therapy approach (treatment with the most empirical evidence) and previous literature about FOD. It consisted of 12 weekly online individual sessions and aimed at improving the FOD diagnosis, sexual variables, and variables that are known to affect orgasm consecution. Control group was based on minimum therapeutic contact. Changes over time in the assessed variables were analyzed using linear mixed models, considering treatment group, measurement time point, and group-by-time interactions as fixed effects. Effect sizes were computed (Cohen's d; number needed to treat - NNT; reliable change index - RCI).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06187246
Study type Interventional
Source Universidad Rey Juan Carlos
Contact
Status Completed
Phase N/A
Start date January 1, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT01607658 - Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder Phase 2
Recruiting NCT03189238 - Platelet Rich Plasma (PRP) Peri-urethral and Clitoral Injections for the Treatment of Female Orgasmic Disorder Phase 2
Completed NCT01803802 - Effects of Early Abuse on Adult Intimate Relationships N/A